H19 and cardiovascular disorder: A variety of LncRNAs has emerged as potential biomarkers and therapeutic targets for diverse cardiovascular diseases, such as CHRF, GAS5, MIAT, CARL, MDRL, H19, APF, NRF, and MALAT123.